Cobar, Freya Venventia .

HRN: 21-22-12  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
AMPICILLIN 250MG (VIAL)
05/28/2022
06/04/2022
IV
80
Q6hours
Pcap
Waiting Final Action 
05/29/2022
AMPICILLIN 250MG (VIAL)
05/29/2022
06/04/2022
IVT
150.mg
Q6
Pcap C
Waiting Final Action 
05/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/29/2022
06/04/2022
IVT
40mg
Q24
Pcap C
Waiting Final Action 
05/30/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/30/2022
06/05/2022
IVT
320mg
Q6
PCAP-C, (+) Seizure
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: